What is the Return on Assets (ROA) of Pulmonx this year?
The Return on Assets (ROA) of Pulmonx is -0.35 undefined this year.
Pulmonx ROA 2025
Pulmonx ROA
-0.35
Ticker
LUNG
ISIN
US7458481014
WKN
A2P1AF
In 2025, Pulmonx's return on assets (ROA) was -0.35, a 1.19% increase from the -0.34 ROA in the previous year.
Pulmonx Aktienanalyse
What does Pulmonx do?
Pulmonx Corp is an innovative medical technology company based in the USA and Europe. The company specializes in the development of non-invasive solutions for the treatment of lung diseases. Pulmonx was founded in 1997 and has since introduced numerous groundbreaking technologies to the market that improve the quality of life for patients with chronic lung diseases. Pulmonx ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Pulmonx's Return on Assets (ROA)
Pulmonx's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Pulmonx's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Pulmonx's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Pulmonx’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Pulmonx stock
What was the ROA of Pulmonx compared to the previous year?
The ROA of Pulmonx has increased by 1.19% compared to the previous year.
What consequences do high ROA have for investors of Pulmonx?
A high ROA is advantageous for investors of Pulmonx, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Pulmonx?
A low ROA can be unfavorable for investors of Pulmonx as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Pulmonx affect the company?
An increase in ROA of Pulmonx can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Pulmonx impact the company?
A reduction in the ROA of Pulmonx can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Pulmonx?
Some factors that can influence the ROA of Pulmonx include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Pulmonx important for investors?
The ROA of Pulmonx is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Pulmonx take to improve ROA?
To improve ROA, Pulmonx can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Pulmonx pay?
Over the past 12 months, Pulmonx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pulmonx is expected to pay a dividend of 0 USD.
What is the dividend yield of Pulmonx?
The current dividend yield of Pulmonx is .
When does Pulmonx pay dividends?
Pulmonx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Pulmonx?
Pulmonx paid dividends every year for the past 0 years.
What is the dividend of Pulmonx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Pulmonx located?
Pulmonx is assigned to the 'Health' sector.
Wann musste ich die Aktien von Pulmonx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Pulmonx from 10/8/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/8/2025.
When did Pulmonx pay the last dividend?
The last dividend was paid out on 10/8/2025.
What was the dividend of Pulmonx in the year 2024?
In the year 2024, Pulmonx distributed 0 USD as dividends.
In which currency does Pulmonx pay out the dividend?
The dividends of Pulmonx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Pulmonx
Our stock analysis for Pulmonx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pulmonx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
